Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study

scientific article published on 09 July 2019

Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S1470-2045(19)30340-7
P698PubMed publication ID31300207

P50authorAndreas LeimbachQ55079381
Martin WidschwendterQ71025350
P2093author name stringAllison Jones
Andy Ryan
Susanne Knapp
David Cibula
Michal Zikan
Nicoletta Colombo
Nuno R Nené
Line Bjørge
John F Timms
Dorella Franchi
Tobias Paprotka
Daniel Reisel
Iona Evans
Shohreh Ghazali
P2860cites workThe vaginal microbiota: what have we learned after a decade of molecular characterization?Q21131955
Basic local alignment search toolQ25938991
Vaginal microbiome of reproductive-age womenQ28284755
The NCBI Taxonomy databaseQ28740981
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequencesQ29547172
The Ribosomal Database Project: improved alignments and new tools for rRNA analysisQ29547434
UCHIME improves sensitivity and speed of chimera detectionQ29547664
FLASH: fast length adjustment of short reads to improve genome assembliesQ29615113
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controlsQ31147531
The ovarian cancer oncobiomeQ33829460
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancerQ34113283
Tubal ligation and the risk of ovarian cancer: review and meta-analysisQ34126227
Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studiesQ34397845
Cancer and the microbiotaQ34470083
Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detectionQ34974847
Comparing High-throughput Platforms for Sequencing the V4 Region of SSU-rDNA in Environmental Microbial Eukaryotic Diversity SurveysQ35329346
Potential contribution of the uterine microbiome in the development of endometrial cancerQ37440393
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersQ38717239
Cervicovaginal Microbiomes-Threats and PossibilitiesQ38821130
Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.Q39135146
The vaginal microbiota, host defence and reproductive physiologyQ40626998
The microbiota continuum along the female reproductive tract and its relation to uterine-related diseasesQ42379632
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.Q44946113
The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infectionsQ45233106
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study.Q45802281
Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based studyQ46609744
False discovery rate, sensitivity and sample size for microarray studies.Q47384576
Ovarian cancerQ54105461
The influence of ethnicity and geography on human gut microbiome compositionQ57059975
Regional variation limits applications of healthy gut microbiome reference ranges and disease modelsQ58045721
Case for a role of the microbiome in gynecologic cancers: Clinician's perspectiveQ90705676
Modulating the microbiome to improve therapeutic response in cancerQ91321458
P433issue8
P921main subjectovarian cancerQ172341
BRCA1 MutationQ28444960
P304page(s)1171-1182
P577publication date2019-07-09
P1433published inLancet Oncology CommissionQ13747613
P1476titleAssociation between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study
P478volume20

Reverse relations

cites work (P2860)
Q94585881An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping
Q89975415Non-Surgical Cancer Risk Reduction in BRCA1 Mutation Carriers: Disabling the Remote Control
Q91837168Of microbes and women: BRCA1, vaginal microbiota, and ovarian cancer
Q90056668Opportunities and Challenges of the Human Microbiome in Ovarian Cancer
Q97527176The Alterations of Vaginal Microbiome in HPV16 Infection as Identified by Shotgun Metagenomic Sequencing
Q93237520Tissue-Specific Carcinogens as Soil to Seed BRCA1/2-Mutant Hereditary Cancers
Q91713074Vaginal microbiomes and ovarian cancer: a review

Search more.